Posted by Michael Wonder on 13 Feb 2025
FDA approves Roche’s Evrysdi tablet as first and only tablet for spinal muscular atrophy
12 February 2025 - New tablet formulation may provide greater freedom and independence for people with spinal muscular atrophy thanks to simplified dose administration
Roche announced today that the US FDA has approved a new drug application for an Evrysdi (risdiplam) tablet for people living with spinal muscular atrophy.
